Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers

Maximillian Otte,Hans Peter Dauben,Jeonghoon Ahn,Iñaki Gutierrez Ibarluzea,Michael Drummond,Steven Simoens,Zoltán Kaló,Dong-Churl Suh
DOI: https://doi.org/10.1080/14737167.2024.2398482
2024-09-04
Expert Review of Pharmacoeconomics & Outcomes Research
Abstract:Introduction This paper summarizes the results from a forum of healthcare experts, academia representatives, and public agency officials from emerging and established market countries on Value-Based Healthcare (VBHC) and Health Technology Assessment (HTA). Presentations from experts provided insights into current developments and challenges, followed by interactive roundtable discussions. Emerging markets have unique healthcare systems, patient populations, resource constraints and needs.
pharmacology & pharmacy,health care sciences & services,health policy & services
What problem does this paper attempt to address?